Libing Xiang

Libing Xiang

Auto-generated profile, based on publicly available information

Libing Xiang

Fudan University, Institute for Ovarian Cancer, Shanghai, China; Fudan University Zhongshan Hospital, Department of Gynecologic Oncology, Shanghai, China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 December 2018 in Journal of Hematology & Oncology
Verified
Journal Article
Open access
PDF file
WJWei Jiang
Wei Jiang
THTiancong He
Tiancong He
SLShuai Liu
Shuai Liu
YZYingying Zheng
Yingying Zheng
LXLibing Xiang
Libing Xiang
HYHuijuan Yang
Huijuan Yang
The study aims to present the effect of PIK3CA E542K and E545K mutations on glucose metabolism and proliferation and identify their underlying mechanisms in cervical cancer. The maximum standard uptake value (SUVmax) of tumors was detected by18F-FDG PET/CT scan. In vitro, glycolysis analysis, extracellular acidification rate analysis, and ATP production were used to evaluate the impact of PIK3CA E542K and E545K mutations on glucose metabolism. The expression level of key glycolytic enzymes was evaluated by western blotting and immunohistochemical staining in cervical cancer cells and tumor tissues, respectively. Immunofluorescence analysis was used to observe the nuclear translocation of β-catenin. The target gene of β-catenin was analyzed by using luciferase reporter system. The glucose metabolic ability of the xenograft models was assessed by SUVmax from microPET/CT scanning. Cervical cancer patients with mutant PIK3CA (E542K and E545K) exhibited a higher SUVmax value than those with wild-type PIK3CA (P = 0.037), which was confirmed in xenograft models. In vitro, enhanced glucose metabolism and proliferation was observed in SiHa and MS751 cells with mutant PIK3CA. The mRNA and protein expression of key glycolytic enzymes was increased. AKT/GSK3β/β-catenin signaling was highly activated in SiHa and MS751 cells with mutant PIK3CA. Knocking down β-catenin expression decreased glucose uptake and lactate production. In addition, the nuclear accumulation of β-catenin was found in SiHa cells and tumors with mutant PIK3CA. Furthermore, β-catenin downregulated the expression of SIRT3 via suppressing the activity of the SIRT3 promotor, and the reduced glucose uptake and lactate production due to the downregulation of β-catenin can be reversed by the transfection of SIRT3 siRNA in SiHa cells with mutant PIK3CA. The negative correlation between β-catenin and SIRT3 was further confirmed in cervical cancer tissues. These findings provide evidence that the PI3K E542K and E545K/β-catenin/SIRT3 signaling axis regulates glucose metabolism and proliferation in cervical cancers with PIK3CA mutations, suggesting therapeutic targets in the treatment of cervical cancers. FUSCC 050432–4-1212B. Registered 24 December 2012 (retrospectively registered).

1 January 2018 in Journal of Gynecologic Oncology
Verified
Journal Article
Open access
PDF file
WJWei Jiang
Wei Jiang
LXLibing Xiang
Libing Xiang
XPXuan Pei
Xuan Pei
THTiancong He
Tiancong He
XSXuxia Shen
Xuxia Shen
HYHuijuan Yang
Huijuan Yang
Jiang W, et al. J Gynecol Oncol. 2017 Sep;29(1):e4. https://doi.org/10.3802/jgo.2018.29.e4

1 January 2020 in Journal of Gynecologic Oncology
Verified
Journal Article
Open access
PDF file
RJRong Jiang
Rong Jiang
JZJianqing Zhu
Jianqing Zhu
HKHak Jae Kim
Hak Jae Kim
JLJihong Liu
Jihong Liu
KKKazuyoshi Kato
Kazuyoshi Kato
RZRongyu Zang
Rongyu Zang
Jiang R, et al. J Gynecol Oncol. 2019 Jun;31:e86. https://doi.org/10.3802/jgo.2020.31.e86

13 January 2023 in Cancer Letters
Verified
Journal Article
Closed access
WJWei Jiang
Wei Jiang
XOXueyan Ouyang
Xueyan Ouyang
ZJZhaodong Ji
Zhaodong Ji
WSWanling Shi
Wanling Shi
YWYutuan Wu
Yutuan Wu
HYHuijuan Yang
Huijuan Yang

5 May 2017 in BMC Cancer
Verified
Journal Article
Open access
PDF file
SYShuang Ye
Shuang Ye
THTiancong He
Tiancong He
SLShanhui Liang
Shanhui Liang
XCXiaojun Chen
Xiaojun Chen
XWXiaohua Wu
Xiaohua Wu
LXLibing Xiang
Libing Xiang
To evaluate the procedures and complications of diaphragm peritonectomy (DP) and diaphragm full-thickness resection (DFTR) during primary cytoreduction for advanced stage epithelial ovarian cancer. All the patients with epithelial ovarian carcinoma who underwent diaphragm procedures at our institution between January 2009 and August 2015 were identified. Clinicopathological data were retrospectively collected from the patients’ medical records. Postoperative morbidities were assessed according to the Memorial Sloan-Kettering Cancer Center (MSKCC) grading system. A total of 150 patients were included in the study. The majority of the patients had ovarian cancer (96%), stage IIIC disease (76%) and serous histology (89.3%). DP and DFTR were performed in 124 (82.7%) and 26 (17.3%) patients, respectively. A total of 142 upper abdominal procedures in addition to the diaphragmatic surgery were performed in 77 (51.3%) patients. No macroscopic residual disease was observed in 35.3% of the patients, while 84% of the total patient cohort had residual disease ≤1 cm. The overall incidence of at least one major morbidity (MSKCC grades 3–5) was 18.0%, whereas pleural effusions (33.3%), pneumonia (15.3%) and pneumothorax (7.3%) were the most commonly reported morbidities. The rate of postoperative pleural drainage was 14.6% in total, while half the patients in the DFTR group received drainage intraoperatively (11.5%) and postoperatively (38.5%). The incidence of postoperative pleural effusion was associated with stage IV disease (hazard ratio [HR], 17.2; 95% confidence interval [CI]: 4.5–66.7; P < 0.001), DFTR (HR, 4.9; 95% CI: 1.2–19.9; P = 0.028) and a long surgery time (HR, 15.4; 95% CI: 4.3–55.5; P < 0.001). Execution of DP and DFTR as part of an extensive upper abdominal procedure resulted in an acceptable morbidity rate. Pleural effusion, pneumonia and pneumothorax were the most common pulmonary morbidities. The pleural drainage rate was not high enough to justify prophylactic chest tube placement for all the patients. However, patients who underwent DFTR merited special consideration for intraoperative prophylactic drainage.

1 January 2023 in Journal of Gynecologic Oncology
Verified
Journal Article
Open access
PDF file
TDTing Deng
Ting Deng
KLKaijiang Liu
Kaijiang Liu
LCLiang Chen
Liang Chen
XCXiaojun Chen
Xiaojun Chen
HLHua Wen Li
Hua Wen Li
JLJihong Liu
Jihong Liu
Deng T, et al. J Gynecol Oncol. 2023 Apr;34:e52. https://doi.org/10.3802/jgo.2023.34.e52